Conversely, expression data from the cancer cell line encyclopaedia database (CCLE) showed widespread repression of EMX2 in a large panel of glioma cell lines, whilst aberrant expression of HOXB9 was detected in 19 lines (RPKM ≥ 5; Fig 3E). Here, HOXB9 is linked to central nervous system cancer.